In the GOAL study, [23] increasing the ICS dose in ICS + LABA combinations (fluticasone proprionate + salmeterol) for 1-year duration improved asthma control, which included a short oral ...
Fluticasone propionate, salmeterol (as xinafoate); 45mcg/21mcg ... Available data show that when ICS and LABA are used together, such as with Advair HFA, there is not a significant increase ...
Seretide/Advair (fluticasone propionate + salmeterol; GlaxoSmithKline) and Symbicort (budesonide + formoterol fumarate dihydrate; AstraZeneca), which are ICS–LABA combinations, are other popular ...
Increased risk of asthma-related death when LABA, such as salmeterol, is used as monotherapy (without ICS). Use of Serevent ... All patients were switched to fluticasone propionate 88 mcg twice ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback